In Vitro Susceptibility of Clinical and Carrier Strains of Staphylococcus aureus to STAFAL® Phage Preparation
Marek Straka, Zuzana Hubenáková, Lucia Janošíková, Aneta Bugalová, Andrej Minich, Martin Wawruch, Adriana Liptáková, Hana Drahovská, Lívia Slobodníková, Wilfried Moreira · 2024
Read In Vitro Susceptibility of Clinical and Carrier Strains of Staphylococcus aureus to STAFAL® Phage Preparation by Marek Straka, Zuzana Hubenáková, Lucia Janošíková, Aneta Bugalová, Andrej Minich, Martin Wawruch, Adriana Liptáková, Hana Drahovská, Lívia Slobodníková, Wilfried Moreira (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641142.txt.
Description
Marek Straka and eight co-authors test how well a phage mix called STAFAL kills Staphylococcus aureus, a germ that more and more strains shield from standard drugs. Phage care uses viruses that attack germs, and this mix is the only one of its kind licensed in its home region. The study came out in twenty twenty-four.
The team tested carrier strains, blood infection strains, and skin infection strains, each with varied drug traits and gene roots. A plaque method read how often the mix cleared each strain. It worked on about three fourths of all strains. Strains that proofed key drugs were in fact more likely to fall to the mix.
Catalog record
| CREATOR | Marek Straka, Zuzana Hubenáková, Lucia Janošíková, Aneta Bugalová, Andrej Minich, Martin Wawruch, Adriana Liptáková, Hana Drahovská, Lívia Slobodníková, Wilfried Moreira |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |